Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue
- PMID: 18664597
- PMCID: PMC2575897
- DOI: 10.1152/ajpendo.90359.2008
Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue
Abstract
The subcutaneous (S) and visceral (V) adipose tissue (AT) depots are increasingly recognized as distinct. To test the hypothesis that depot differences exist for adiponectin, fresh and cultured human VAT and SAT from obese type 2 diabetic (T2D) and obese nondiabetic (ND) subjects was examined to determine whether differences in adiponectin content and secretion occurred as a function of depot studied, diabetic status, and response to thiazolidinedione treatment. VAT and SAT were obtained by biopsy and AT explants cultured in defined media for 7 days. Protein expression was assessed by Western blot. Adiponectin content of conditioned medium was determined by radioimmunoassay. Diabetic status had no effect on adiponectin secretion over days 0-2 of culture. In ND SAT, secretion fell over days 2-4 but was sustained at greater levels vs. T2D SAT. In both ND and T2D VAT, adiponectin secretion was low, similar to T2D SAT. Over the 7-day culture period, cellular adiponectin increased in ND SAT and VAT; it remained unchanged in T2D SAT and VAT. Pioglitazone increased adiponectin secretion and content in all SAT. Pioglitazone failed to increase adiponectin secretion from either ND or T2D VAT and increased cellular content only in ND VAT. AT depot differences exist in the secretion of adiponectin and responsiveness to thiazolidinedione treatment. These data suggest that SAT, not VAT, appears to be the major contributor to increased circulating adiponectin levels in response to pioglitazone treatment.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2575897/bin/zh10100854380001.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2575897/bin/zh10100854380002.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2575897/bin/zh10100854380003.gif)
![Fig. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2575897/bin/zh10100854380004.gif)
![Fig. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2575897/bin/zh10100854380005.gif)
Similar articles
-
Regulation of adiponectin secretion in human subcutaneous and omental adipose tissue: effects of pioglitazone and endothelin-1: a pilot study.J Assoc Physicians India. 2013 Apr;61(4):244-8. J Assoc Physicians India. 2013. PMID: 24482963
-
The impact of obesity on secretion of adiponectin multimeric isoforms differs in visceral and subcutaneous adipose tissue.Int J Obes (Lond). 2012 Oct;36(10):1360-5. doi: 10.1038/ijo.2011.223. Epub 2011 Dec 6. Int J Obes (Lond). 2012. PMID: 22143618
-
Adiponectin synthesis and secretion by subcutaneous adipose tissue is impaired during obesity by endoplasmic reticulum stress.J Cell Biochem. 2018 Jul;119(7):5970-5984. doi: 10.1002/jcb.26794. Epub 2018 Mar 25. J Cell Biochem. 2018. PMID: 29575057
-
Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome.Horm Metab Res. 2002 Nov-Dec;34(11-12):616-21. doi: 10.1055/s-2002-38256. Horm Metab Res. 2002. PMID: 12660870 Review.
-
The relationship of obesity to the metabolic syndrome.Int J Clin Pract Suppl. 2003 Mar;(134):18-27. Int J Clin Pract Suppl. 2003. PMID: 12793594 Review.
Cited by
-
Metabolic effects of lipectomy and of adipose tissue transplantation.Obesity (Silver Spring). 2023 Jan;31(1):7-19. doi: 10.1002/oby.23601. Epub 2022 Dec 7. Obesity (Silver Spring). 2023. PMID: 36479639 Free PMC article. Review.
-
Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise.Int J Environ Res Public Health. 2021 Dec 17;18(24):13333. doi: 10.3390/ijerph182413333. Int J Environ Res Public Health. 2021. PMID: 34948944 Free PMC article. Review.
-
Adipokine signatures of subcutaneous and visceral abdominal fat in normal-weight and obese women with different metabolic profiles.Arch Med Sci. 2021 Feb 26;17(2):323-336. doi: 10.5114/aoms/92118. eCollection 2021. Arch Med Sci. 2021. PMID: 33747267 Free PMC article.
-
A Comparative Peptidomic Characterization of Cultured Skeletal Muscle Tissues Derived From db/db Mice.Front Endocrinol (Lausanne). 2019 Oct 29;10:741. doi: 10.3389/fendo.2019.00741. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31736878 Free PMC article.
-
Reference Gene Optimization for Circadian Gene Expression Analysis in Human Adipose Tissue.J Biol Rhythms. 2020 Feb;35(1):84-97. doi: 10.1177/0748730419883043. Epub 2019 Oct 31. J Biol Rhythms. 2020. PMID: 31668115 Free PMC article.
References
-
- Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46: 860–867, 1997. - PubMed
-
- Appel B, Fried SK. Effects of insulin and dexamethasone on lipoprotein lipase in human adipose tissue. Am J Physiol Endocrinol Metab 262: E695–E699, 1992. - PubMed
-
- Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79–83, 1999. - PubMed
-
- Bodles AM, Banga A, Rasouli N, Ono F, Kern PA, Owens RJ. Pioglitazone increases secretion of high-molecular-weight adiponectin from adipocytes. Am J Physiol Endocrinol Metab 291: E1100–E1105, 2006. - PubMed
-
- Bolinder J, Kager L, Ostman J, Arner P. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 32: 117–123, 1983. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials